Supreme Court Rules For Big Pharma In Integra v. Merck

Law360, New York (June 13, 2005, 12:00 AM EDT) -- In a landmark decision with broad implications for the pharmaceutical industry, the U.S. Supreme Court has ruled that drug makers can ignore their competitors' patents during research on rival treatments.

In a unanimous decision, the nation’s highest court set aside a ruling by the U.S. Court of Appeals for the Federal Circuit in favor of patent holder Integra LifeSciences Holdings Corp. in a patent dispute with drug maker Merck KGaA of Germany.

The Court agrees with the government that “the use of patented compounds in preclinical...
To view the full article, register now.